Posted in | News | Materials Analysis

Characterizing Pharmaceutical Cream In New Application Note From Malvern Instruments

The application of morphologically directed Raman spectroscopy to characterizing the component-specific particulate properties of the active components in a topical pharmaceutical cream is described in an application note from Malvern Panalytical.

 

The Morphologi G3-ID allows component specific characterization of distributions within a pharmaceutical blend.

 

While it is relatively straightforward to determine the particle size distributions of the individual components of a drug formulation before they are formulated as a blend, doing so post-blending is more challenging. Now, the Morphologi G3-ID, which combines automated image analysis with Raman spectroscopy in a single instrument, enables component-specific particle size and shape distributions to be obtained from a blend. The results of this analysis can provide information about the homogeneity and potency of individual components.

Such insight is helpful in improving product understanding and can be applied from a regulatory perspective right through to troubleshooting and optimizing manufacturing processes.

Component specific particle characterization of active component(s) in topical cream products’ is freely downloadable from the Malvern Panalytical website. It details the analysis of a commercially available topical cream containing two active ingredients.

These two morphologically similar actives could not be differentiated by image analysis alone, however the combination of image analysis with Raman spectroscopy allowed the unambiguous determination of particle size distribution for each component. 

The Morphologi G3-ID provides size, shape and chemical analysis information for particles in the size range 0.5 µm – 1000 µm for a variety of sample types, including dry powders, liquids and creams. It operates by scanning a particle dispersion and using advanced optics to capture images of individual particles.

The system then automatically selects particles within the dispersion and collects a Raman spectrum from each one, allowing them to be classified and grouped in terms of discrete component populations. Designed for operational ease of use, the fully automated instrument enables particle characterization scientists with even limited spectroscopic experience to gain an in-depth understanding of their particulate samples.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2021, March 09). Characterizing Pharmaceutical Cream In New Application Note From Malvern Instruments. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=39903.

  • MLA

    Malvern Panalytical. "Characterizing Pharmaceutical Cream In New Application Note From Malvern Instruments". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=39903>.

  • Chicago

    Malvern Panalytical. "Characterizing Pharmaceutical Cream In New Application Note From Malvern Instruments". AZoM. https://www.azom.com/news.aspx?newsID=39903. (accessed November 21, 2024).

  • Harvard

    Malvern Panalytical. 2021. Characterizing Pharmaceutical Cream In New Application Note From Malvern Instruments. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=39903.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.